Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Gee

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Archives of General Psychiatry|November 3, 2004
A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorderKaren Dineen Wagner, Ray Berard, Murray B Stein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2025
Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open-label extension studyChristopher H van Dyck, Reisa Sperling, Keith Johnson, et al.
ACS Omega|June 19, 2023
Systems Engineering Approach to Modeling and Analysis of Chronic Obstructive Pulmonary DiseaseVarghese Kurian, Navid Ghadipasha, Michelle Gee, et al.
Journal of Psychopharmacology (Oxford, England)|April 5, 2014
Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approachAmir Inamdar, Emilio Merlo-Pich, Michelle Gee, et al.
Epilepsia|August 22, 2012
Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307Gregory L Krauss, Emilio Perucca, Elinor Ben-Menachem, et al.
Advanced Healthcare Materials|June 10, 2022
Bioengineered 3D Tissue Model of Intestine Epithelium with Oxygen Gradients to Sustain Human Gut MicrobiomeYing Chen, Sara E Rudolph, Brooke N Longo, et al.
Epilepsia|May 29, 2014
Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307Gregory L Krauss, Emilio Perucca, Elinor Ben-Menachem, et al.
Cell|May 21, 2013
Cell-cell communication between malaria-infected red blood cells via exosome-like vesiclesNeta Regev-Rudzki, Danny W Wilson, Teresa G Carvalho, et al.
Annals of Neurology|October 13, 2023
Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer DiseaseJoshua D Grill, Charlene Flournoy, Shobha Dhadda, et al.
Alzheimer'S Research & Therapy|July 27, 2022
Evaluation of tau deposition using <sup>18</sup>F-PI-2620 PET in MCI and early AD subjects-a MissionAD tau sub-studySantiago Bullich, Andre Mueller, Susan De Santi, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Archives of General Psychiatry|November 3, 2004
A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorderKaren Dineen Wagner, Ray Berard, Murray B Stein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2025
Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open-label extension studyChristopher H van Dyck, Reisa Sperling, Keith Johnson, et al.
ACS Omega|June 19, 2023
Systems Engineering Approach to Modeling and Analysis of Chronic Obstructive Pulmonary DiseaseVarghese Kurian, Navid Ghadipasha, Michelle Gee, et al.
Journal of Psychopharmacology (Oxford, England)|April 5, 2014
Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approachAmir Inamdar, Emilio Merlo-Pich, Michelle Gee, et al.
Epilepsia|August 22, 2012
Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307Gregory L Krauss, Emilio Perucca, Elinor Ben-Menachem, et al.
Advanced Healthcare Materials|June 10, 2022
Bioengineered 3D Tissue Model of Intestine Epithelium with Oxygen Gradients to Sustain Human Gut MicrobiomeYing Chen, Sara E Rudolph, Brooke N Longo, et al.
Epilepsia|May 29, 2014
Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307Gregory L Krauss, Emilio Perucca, Elinor Ben-Menachem, et al.
Cell|May 21, 2013
Cell-cell communication between malaria-infected red blood cells via exosome-like vesiclesNeta Regev-Rudzki, Danny W Wilson, Teresa G Carvalho, et al.
Annals of Neurology|October 13, 2023
Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer DiseaseJoshua D Grill, Charlene Flournoy, Shobha Dhadda, et al.
Alzheimer'S Research & Therapy|July 27, 2022
Evaluation of tau deposition using <sup>18</sup>F-PI-2620 PET in MCI and early AD subjects-a MissionAD tau sub-studySantiago Bullich, Andre Mueller, Susan De Santi, et al.
Pageof 3